FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

Leonhard Klein Prize 2021: Prof. Heindl won Germany´s top research award in Ophthalmology

heindl_ludwig

heindl_ludwig

Prof. Dr. Dr. Ludwig Heindl, head of the section of Ophthalmooncology and Ophthalmoplastic Surgery at the University Eye Hospital Cologne and FOR 2240 member, won the Leonard Klein Prize 2021 for his innovative work on improving laser-assisted, minimally invasive lacrimal duct surgery. The prize has been awarded at the annual meeting of the German Ophthalmological Society (DOG) and is the highest prize in ophthalmological research in Germany.

Advances in the fields of endoscopy and laser surgery have enabled Prof. Heindl to develop two new bypass procedures for the treatment of lacrimal duct stenosis, a narrowing of the draining tear ducts, with excellent success rates in recent years.
In transcanalicular laser-assisted dacryocystorhinostomy, the surgeon inserts a laser fiber through the lacrimal duct and creates a bony ostium toward the nose using laser energy under nasal endoscopic control. In transcaruncular laser-assisted StopLoss-Lester Jones tube surgery, experts insert the laser fiber through a caruncular incision and laser a bony ostium toward the nose, then individually measure and implant a Pyrex glass tube. Both procedures avoid skin incisions in the patient’s face.

“We are very happy that with Prof. Heindl we have a nationally and internationally renowned pioneer in the field of lacrimal duct and eye tumor surgery at the University Hospital in Cologne. The fact that he won the award for the second time after 2017 is a great success,” congratulates Prof. Dr. Claus Cursiefen, Director of the Department of Ophthalmology at the University Hospital of Cologne and speaker of FOR 2240.

Related posts

January 7, 2023

Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface


Read more
December 15, 2022

Leonhard Klein-Preis for Prof. Matthaei


Read more
November 22, 2022

4th Shanghai-Cologne Scientific Symposium


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck